Nicholas Butowski, MD

Nicholas Butowski, MD, associate professor, University of California, San Francisco, neuro-oncologist, UCSF Medical Center, discusses a phase I study of convection-enhanced delivery of nanoliposomal irinotecan (MM-398) for the treatment of recurrent glioblastoma or recurrent high-grade glioma.

1-3 catheters co-deliver liposomal-irinotecan and gadolinium into a patient&rsquo;s tumor.

Gadolinium is used so that imaging can be done in real-time.

This process is unique because it bypasses systemic toxicity and ensures that the drug is administered properly.

Articles

Nicholas Butowski, MD, discusses a phase I study of convection-enhanced delivery of nanoliposomal irinotecan (MM-398) for the treatment of recurrent glioblastoma or recurrent high-grade glioma.

Nicholas Butowski, MD | Authors

Articles

Convection-Enhanced Delivery of Nanoliposomal Irinotecan for Recurrent Glioblastoma or High-Grade Glioma